Bacterial vaccines and serotype replacement: Lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae

Emerging Infectious Diseases

Volumn 5, Issue 3, 1999, Pages 336-345

  Lipsitch, Marc ^a,b  

^a EMORY UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE;

BACTERIAL COLONIZATION; DISEASE TRANSMISSION; DRUG DESIGN; HAEMOPHILUS INFLUENZAE TYPE B; IMMUNITY; MATHEMATICAL MODEL; REVIEW; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VACCINATION;

EID: 0033059668     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0503.990304     Document Type: Review

References (47)

1. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46:RR8.
2. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1987-1995. MMWR Morb Mortal Wkly Rep 1996;45.901-6.
3. Booy R, Kroll JS. Is Haemophilus influenzae finished? J Antimicrob Chemother 1997;40:149-53.
4. Dagan R, Melamed R, Muallem M, Piglansky L, Greenberg D, Abramson O, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996;174:1271-8.
5. Obaro SK, Adegbola RA, Banya WAS, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996;348:271-2.
6. Mbelle N, Wasas A, Huebner R, Kimura A, Chang I, Klugman K. Immunogemcity and impact on carriage of 9-valent pneumococcal conjugate vaccine given to infants in Soweto, South Africa. Proceedings from the Interscience Conference on Antimicrobial Agents and Chemotherapy; September 28-October 1, 1997; Toronto, Canada. LB-12, p. 13.
7. 197 (PncCRM9) on nasopharyngeal (NP) carriage of vaccine type and non-vaccine type S. pneumoniae (Pnc) strains among day-care-center (DCC) attendees. Proceedings from the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 24-27, 1998; San Diego, California. G52.
8. Black S, Shinefield H, Ray P, Lewis E, Fireman B, The Kaiser Permanente Vaccine Study Group. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: results of the Northern California Kaiser Permanente Efficacy Trial. Proceedings from the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 24-27, 1998; San Diego, California. LB-9.
9. Barbour ML. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg Infect Dis 1996;2.176-82.
10. Moxon ER. The carrier state: Haemophilus influenzae. J Antimicrob Chemother 1986;18 Suppl A:17-24.
11. Austrian R. Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 1986; 18 Suppl A:35-45.
12. Lipsitch M, Moxon ER. Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol 1997;5:31-7.
13. Topley WWC. The spread of bacterial infection. Lancet 1919;July 5:1-5.
14. Levin BR, Bull JJ. Short-sighted evolution and the virulence of pathogenic microbes. Trends Microbiol 1994;2:76-81.
15. Barbour ML, Mayon-White RT, Coles C, Crook DWM, Moxon ER. The impact of conjugate vaccine on carnage of Haemophilus influenzae type b. J Infect Dis 1995;171:93-8
16. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
17. Wenger JD, Pierce R, Deaver K, Franklin R, Bosley G, Pigott N, et al. Invasive Haemophilus influenzae disease: a population-based evaluation of the role of capsular polysaccharide serotype. J Infect Dis 1992;165 Suppl 1:S34-5.
18. Farley MM, Stephens DS, Brachman PS Jr. Invasive Haemophilus influenzae disease in adults: a prospective, population-based surveillance. Ann Inter Med 1992;116 806-12.
19. Nitta DM, Jackson MA, Burry VF, Olson LC. Invasive Haemophilus influenzae type f disease. Pediatr Infect Dis J 1995;14:157-60.
20. Greene GR. Meningitis due to Haemophilus influenzae other than type b: case report and review. Pediatrics 1978,62:1021-5.
21. Takala AK, Eskola J, Leinonen M, Kayhty H, Nissinen A, Pekkanen E, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;164:982-6.
22. Booy R, Heath P, Willocks L, Mayon-White D, Slack M, Moxon R. Invasive pneumococcal infections in children Lancet 1995;345:1245-6.
23. Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM, Group HIS. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiological characteristics in the H. influenzae serotype b vaccine era. Clin Infect Dis 1996;22:1069-76.
24. Baer M, Vuento R, Vesikari T. Increase in bacteraemic pneumococcal infections in children. Lancet 1995;345:661.
25. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997;337.970-6.
26. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1991.
27. Hodges RG, MacLeod CM, Bernhard WG. Epidemic pneumococcal pneumonia. III. Carrier studies. American Journal of Hygiene 1946;44:207-30.
28. Pradier C, Dunais B, Carsenti-Etesse H, Largillier R, Bernard E, Dellamonica P. Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae (PRSP) prevalence and incidence in three children's day-care centres in Nice, France, from 1994 to 1995. Proceedings from the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 15-18, 1996, New Orleans, Louisiana. C56.
29. Reichler MR, Allphin AA, Breiman RF, Schreiber JR, Arnold JE, McDougal LK, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
30. Sanders CC, Sanders WE Jr, Harrowe DJ. Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci. Infect Immun 1976;13:808-12.
31. Johanson WG Jr, Blackstock R, Pierce AK, Sanford JP. The role of bacterial antagonism in pneumococcal colonization of the human pharynx. J Lab Clin Med 1970;75:946-52.
32. Venezia RA, Robertson RG. Bactericidal substance produced by Haemophilus influenzae type b. Can J Microbiol 1975;21:1587-94.
33. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A 1997;94:6571-6.
34. Sutton A, Schneerson R, Kendall-Morris S, Robbins JB. Differential complement resistance mediates virulence of Haemophilus influenzae type b. Infect Immun 1982;35:95-104.
35. Smith T, Lehmann D, Montgomery J, Gratten M, Riley ID, Alpers MP. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 1993;111:27-39.
36. Ewald PW. Vaccines as evolutionary tools: the virulence-antigen strategy. In: Kaufmann SHE, editor. Concepts in vaccine development. Berlin: Walter de Gruyter; 1996.
37. Moxon ER, Vaughn KA. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J Infect Dis 1981;14:517-24.
38. Kelly T, Dillard JP, Yother J. Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae. Infect Immun 1994;62:1813-9.
39. Barnes DM, Whittier S, Gilligan PH, Soares S, Tomasz A, Henderson FW. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis 1995;171:890-6.
40. Takala AK, Vuopio-Varldla J, Tarkka E, Leinonen M, Musser JM. Subtyping of common pediatric pneumococcal serotypes from invasive disease and pharyngeal carriage in Finland. J Infect Dis 1996;173:128-35.
41. Gratten M, Montgomery J, Gerega G, Gratten H, Siwi H, Poli A, et al. Multiple colonization of the upper respiratory tract of Papua New Guinea children with Haemophilus influenzae and Streptococcus pneumoniae. Southeast Asian Journal of Tropical Medicine and Public Health 1989;20:501-509.
42. Gilks WR, Spiegelhalter DJ. A language and program for complex Bayesian modeling. The Statistician 1994;43:169-78.
43. Spiegelhalter DJ, Thomas A, Best NG, Gilks WR. BUGS: Bayesian inference using Gibbs sampling. Version 0.50. Cambridge: MRC Biostatistics Unit; 1995.
44. Musher DM, Groover JE, Reichler MR, Riedo FX, Schwarz B, Watson DA, et al. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis 1997;24:441-6.
45. Dagan R, Melamed R, Muallem M, Piglansky L, Yagupsky P. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis 1996;174:1352-5.
46. Butler JC. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations. Microb Drug Resist 1997;3:125-9.
47. Paton JC. Novel pneumococcal surface proteins: role in virulence and vaccine potential. Trends Microbiol 1998;6:85-7.